Beyond Mutations: A Seven-CpG DNA Methylation Signature for Predicting HRD in MMRd Colorectal Cancer

We previously identified a high level of molecular heterogeneity within mismatch repair deficiency (MMRd) colorectal cancer (CRC). Despite MMRd CRC being typically considered suitable for immunotherapy, only less than half of the metastatic CRC (mCRC) patients achieve complete remission. Thus, the search for identifying new therapeutic targets has become extremely urgent. The use of poly (ADP-ribose) polymerase inhibitor (PARPi) has revolutionized the treatment of homologous recombination deficiency (HRD) cancer; however, the HRD prevalence in CRC remains unclear. Here, we conducted an integrated analysis of genomic and methylation profiles from a cohort of Chinese MMRd CRC tumors. We successfully developed a novel DNA methylation signature that can effectively stratify MMRd tumors based on their HRD status. The findings suggest that within the MMRd CRC subgroup, more than half of tumors exhibit a concomitant HRD phenotype characterized by hypermethylation. The newly developed methylation-based classifier showed high performance in predicting HRD, offering a promising molecular tool for refining patient stratification. This study highlights the epigenetic heterogeneity of MMRd CRC and proposes a novel, methylation-based signature for identifying tumors with HRD, which may have implications for therapeutic strategies targeting DNA repair vulnerabilities.

Authors

Institutions

Publication Details

Journal
Current Oncology
Published
2026-11-19
DOI
https://doi.org/10.3390/curroncol33110716
Primary Topic
Genetic factors in colorectal cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Beyond Mutations: A Seven-CpG DNA Methylation Signature for Predicting HRD in MMRd Colorectal Cancer

Wangxiong Hu, Xu Zhang, Hao Xu
Current Oncology
Genetic factors in colorectal cancer
article

Beyond Mutations: A Seven-CpG DNA Methylation Signature for Predicting HRD in MMRd Colorectal Cancer

Wangxiong Hu, Xu Zhang, Hao Xu
article en

Abstract

We previously identified a high level of molecular heterogeneity within mismatch repair deficiency (MMRd) colorectal cancer (CRC). Despite MMRd CRC being typically considered suitable for immunotherapy, only less than half of the metastatic CRC (mCRC) patients achieve complete remission. Thus, the search for identifying new therapeutic targets has become extremely urgent. The use of poly (ADP-ribose) polymerase inhibitor (PARPi) has revolutionized the treatment of homologous recombination deficiency (HRD) cancer; however, the HRD prevalence in CRC remains unclear. Here, we conducted an integrated analysis of genomic and methylation profiles from a cohort of Chinese MMRd CRC tumors. We successfully developed a novel DNA methylation signature that can effectively stratify MMRd tumors based on their HRD status. The findings suggest that within the MMRd CRC subgroup, more than half of tumors exhibit a concomitant HRD phenotype characterized by hypermethylation. The newly developed methylation-based classifier showed high performance in predicting HRD, offering a promising molecular tool for refining patient stratification. This study highlights the epigenetic heterogeneity of MMRd CRC and proposes a novel, methylation-based signature for identifying tumors with HRD, which may have implications for therapeutic strategies targeting DNA repair vulnerabilities.

Current OncologyVol. 33(11)
Second Affiliated Hospital of Zhejiang University (CN), Zhejiang University (CN)
Genetic factors in colorectal cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon